HHLR ADVISORS, LTD. - Q2 2019 holdings

$4.47 Billion is the total value of HHLR ADVISORS, LTD.'s 43 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 43.3% .

 Value Shares↓ Weighting
BGNE  BEIGENE LTDsponsored adr$550,084,000
-6.1%
4,437,9530.0%12.30%
-24.6%
JD BuyJD COM INCspon adr cl a$477,082,000
+5.2%
15,750,469
+4.7%
10.67%
-15.6%
TAL  TAL EDUCATION GROUPsponsored ads$434,738,000
+5.6%
11,410,4530.0%9.72%
-15.2%
IQ BuyIQIYI INCsponsored ads$299,632,000
-0.2%
14,510,018
+15.5%
6.70%
-19.9%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$262,189,000
+4.4%
2,751,2000.0%5.86%
-16.2%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$239,235,000
-7.1%
1,411,8300.0%5.35%
-25.4%
FB  FACEBOOK INCcl a$227,663,000
+15.8%
1,179,6000.0%5.09%
-7.0%
EDU BuyNEW ORIENTAL ED & TECH GRP Ispon adr$164,431,000
+65150.4%
1,702,534
+60704.8%
3.68%
+52428.6%
PDD BuyPINDUODUO INCsponsored ads$148,494,000
+91.2%
7,197,978
+129.8%
3.32%
+53.5%
WUBA New58 COM INCspon adr rep a$146,767,0002,360,742
+100.0%
3.28%
SE  SEA LTDsponsored ads$142,846,000
+41.2%
4,300,0000.0%3.19%
+13.4%
BPMC  BLUEPRINT MEDICINES CORP$141,355,000
+17.8%
1,498,5160.0%3.16%
-5.4%
MDLZ SellMONDELEZ INTL INCcl a$137,260,000
-8.8%
2,546,564
-15.5%
3.07%
-26.8%
BILI BuyBILIBILI INCspons ads rep z$131,632,000
+101.2%
8,090,463
+134.4%
2.94%
+61.5%
FGEN BuyFIBROGEN INC$123,094,000
+13.1%
2,724,519
+36.0%
2.75%
-9.2%
TSLA NewTESLA INC$116,329,000520,580
+100.0%
2.60%
MLCO  MELCO RESORT AND ENTMT LTDadr$95,475,000
-3.9%
4,395,7000.0%2.14%
-22.8%
ESGR  ENSTAR GROUP LIMITED$94,719,000
+0.2%
543,4870.0%2.12%
-19.6%
APLS  APELLIS PHARMACEUTICALS INC$65,370,000
+29.9%
2,579,7080.0%1.46%
+4.4%
SNAP NewSNAP INCcl a$63,862,0004,465,885
+100.0%
1.43%
BBIO NewBRIDGEBIO PHARMA INC$63,458,0002,352,900
+100.0%
1.42%
MYOK  MYOKARDIA INC$48,936,000
-3.6%
975,9870.0%1.09%
-22.6%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$36,111,000
-12.4%
3,985,7970.0%0.81%
-29.7%
MOMO NewMOMO INCadr$34,679,000968,693
+100.0%
0.78%
LN  LINE CORPsponsored adr$33,986,000
-20.1%
1,207,7630.0%0.76%
-35.9%
GTHX  G1 THERAPEUTICS INC$29,110,000
+84.7%
949,4310.0%0.65%
+48.3%
KNSA  KINIKSA PHARMACEUTICALS LTD$24,858,000
-25.0%
1,835,8880.0%0.56%
-39.8%
TME  TENCENT MUSIC ENTMT GROUPspon ads$22,043,000
-17.2%
1,470,4910.0%0.49%
-33.5%
GOSS  GOSSAMER BIO INC$20,794,000
+2.4%
937,5000.0%0.46%
-17.8%
ZM NewZOOM VIDEO COMMUNICATIONS INcl a$19,978,000225,000
+100.0%
0.45%
MOGU NewMOGU INCspon ads$14,887,0005,223,485
+100.0%
0.33%
ARVN  ARVINAS INC$13,744,000
+49.0%
625,0000.0%0.31%
+19.5%
SOHU  SOHU COM LTDsponsored ads$11,228,000
-15.6%
802,0340.0%0.25%
-32.2%
RGNX NewREGENXBIO INC$10,582,000206,000
+100.0%
0.24%
AKRO NewAKERO THERAPEUTICS INC$8,139,000425,000
+100.0%
0.18%
EIDX  EIDOS THERAPEUTICS INC$5,551,000
+32.5%
178,6000.0%0.12%
+6.0%
RCUS  ARCUS BIOSCIENCES INC$3,379,000
-36.3%
425,0000.0%0.08%
-48.6%
BYND NewBEYOND MEAT INC$2,410,00015,000
+100.0%
0.05%
HOOK NewHOOKIPA PHARMA INC$1,923,000285,714
+100.0%
0.04%
NXTC NewNEXTCURE INC$1,124,00075,000
+100.0%
0.02%
CIH NewCHINA INDEX HLDGS LTDspnsrd ads a$1,065,000300,000
+100.0%
0.02%
SFUN  FANG HLDGS LTDadr$932,000
-54.0%
1,500,0000.0%0.02%
-62.5%
NEW  PUXIN LTDads$792,000
-9.4%
126,1450.0%0.02%
-25.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings